Arrowhead Pharmaceuticals
ARWR
#2055
Rank
A$13.93 B
Marketcap
A$99.56
Share price
0.30%
Change (1 day)
207.70%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) Fails to deliver data

Key failure to deliver metrics for Arrowhead Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Arrowhead Pharmaceuticals (ARWR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Arrowhead Pharmaceuticals (ARWR) - since 2016

Volume in USD (price x number of shares), data since 2016

Arrowhead Pharmaceuticals (ARWR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$0.89 M-90.76%
2025A$9.71 M-0.81%
2024A$9.79 M55.71%
2023A$6.28 M39.55%
2022A$4.5 M-73.07%
2021A$16.73 M-49.26%
2020A$32.99 M-52.98%
2019A$70.16 M188.2%
2018A$24.34 M233.16%
2017A$7.3 M-4.53%
2016A$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
A$24.94 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A$31.67 MA$74.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$2.08 MA$10.07 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$9.93 MA$38.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A$3.82 MA$10.19 M๐Ÿ‡บ๐Ÿ‡ธ USA